Prevention Valuation: Fund Health, Not Just Sav...

By Rene Pretorius

May 9, 2025

Prevention promises healthier lives, but how should we value it? Prevention valuation is critical for funding in value-based care systems. The proverb "
Implementing Health Technology Assessment in Oman
Targeting Shared Risk Pathways to Prevent Stroke, Dementia, and Depression
Approval of Pembrolizumab Enfortumab Therapy: Insights on Efficacy, Costs, an...
Engineering Resilience: Mastering Pharma Patent Expiration Strategy
Surrogate Endpoints Guidance: New International Report Enhances HTA Practices
Advancing EU Health Technology Assessment: Insights from the HAG Meeting
Cost-Effectiveness of Switching to the Nonavalent HPV Vaccine in the Netherlands
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
Diabetes Management and Economic Burden in Saudi Arabia
CHEERS-AI Economic Evaluation
NICE Rejects Donanemab for NHS Use Due to Cost Concerns
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs